• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG M.BLUE PLUS VALVE; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG M.BLUE PLUS VALVE; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX804T
Medical Device Problem Codes Obstruction of Flow (2423); Physical Resistance/Sticking (4012)
Health Effect - Clinical Code Hydrocephalus (3272)
Date of Event 05/21/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Visual inspection: during the investigation, no significant deformations or damages of the valves were determined.Permeability test: a permeability test has shown that both valves are permeable.Computer controlled test: to investigate the claim of under-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valves are tested in both the horizontal as well as the vertical position.The results show that the valves are operating within the specified tolerances in their respective relevant position.Adjustment test: the valves were tested and the progav 2.0 is adjustable, but the m.Blue is not adjustable to all pressure settings.Braking force and brake function test: the brake functionality test has shown that the brake function operates as expected for both valves.However, the braking force cannot be measured in the m.Blue due to the non-adjustability of the valve.Internal inspection: after dismantling of the valves, organic deposits were found in both valves.To make the deposits in the valves more visible, they were colored with a staining solution.Results: based on our investigation results, we can determine adjustment difficulties in the m.Blue.The determined organic deposits can be named as the cause for the functional deviation.Organic matter in the cerebrospinal fluid can influence the function temporarily and are known inherent side effects in hydrocephalus therapy.Furthermore, we can determine organic deposits in the progav 2.0.The deposits had no effect to the technical properties at the time of the investigation.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
 
Event or Problem Description
It was reported that an m.Blue plus(#fx804t) was implanted during a procedure performed on (b)(6) 2024.According to the complainant, the shunt system caused an blockage and had adjustment difficulties.The patient underwent a revision procedure on (b)(6) 2025.No patient complications were reported as a result of the revision procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
M.BLUE PLUS VALVE
Common Device Name
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key22309052
Report Number3004721439-2025-00164
Device Sequence Number7937391
Product Code JXG
UDI-Device Identifier04041906504793
UDI-Public4041906504793
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K192266
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 06/23/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberFX804T
Device Catalogue NumberFX804T
Device Lot Number20074467
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/27/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/27/2025
Initial Report FDA Received Date06/23/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/04/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age20 MO
Patient SexUnknown
Patient Weight11 KG
-
-